SIH Partners’s Merck MRK Stock Holding History

SIH Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-425,200	Closed	-$42.3M	–	300
2024 Q4	$42.3M	Buy	+425,200	New	+$43.8M	2.14%	10

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SIH Partners's MRK Position: Q2 2025 in Review

SIH Partners sold out of Merck (MRK) in Q2 2025, closing a stake of 23,887 shares — an estimated $2.14M sold.

SIH Partners first reported a position in MRK in Q1 2025 and held it in 1 quarter. The position peaked at $2.14M in Q1 2025. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

SIH Partners reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
SIH Partners sold 23,887 Merck shares in Q2 2025, an estimated $2.14M.
SIH Partners first reported a position in Merck in Q1 2025 and held it in 1 quarter.
SIH Partners's Merck position peaked at $2.14M in Q1 2025.
3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on SIH Partners's 13F filing for Q2 2025, filed 14 Aug 2025.